Drug application
TIROFIBAN HYDROCHLORIDE (TIROFIBAN HYDROCHLORIDE)
Drugs@FDA ANDA 213947 · NEXUS
Key facts
| Drug name | TIROFIBAN HYDROCHLORIDE |
|---|---|
| Active ingredients | TIROFIBAN HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 213947 |
| Company | NEXUS |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jul 24, 2023 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: